Teva Pharmaceuticals has been developing and producing medicines to help improve people’s lives for more than a century. We are committed to being a global leader in generic and specialty medicines with a portfolio of 3,500 products in nearly every therapeutic area. Around 200 million people around the world take a Teva medicine every day. They are served by one of the largest and most complex supply chains in the pharmaceutical industry. Along with our established presence in generics, we have significant innovative research and operations supporting our growing portfolio of specialty and biopharmaceutical products. Learn more at www.tevapharm.com.
Please note that adverse effects for any of our products should be reported to: Safety.AE@teva.co.il
Product-specific questions should be directed to Teva or Teva Group subsidiaries in your country. Contact details and Teva's Pharmacovigilance Privacy Policy may be found here:
http://www.tevapharm.com/contact_us/
generic medicines, specialty medicines, CNS, active pharmaceutical ingredients, respiratory, biosimilars, biologics, pain care, migraine, and oncology
Entity | Type | Tweets | Articles | |
---|---|---|---|---|
Boston College Center for Corporate Citizenship edtech, Research Services | Other 26 Sep 2023 | | ||
Jennifer Brown Consulting consulting, Professional Training and Coaching | Other 29 Sep 2023 | | ||
PHARMAZON e-commerce, healthtech, Retail | Other 20 Sep 2023 | | ||
INTRALOGISTICA ITALIA 27 - 30 Maggio 2025 transporttech, Truck Transportation | Other 30 Jun 2023 | | ||
Entreprises Occitanie Newspaper Publishing | Other 4 Aug 2023 | | ||
CHEManager International Newspaper Publishing | Other 10 Jul 2023 | | ||
LJMU Student Futures Higher Education, edtech | Other 24 Oct 2018 | | ||
NZZ Newspaper Publishing | Other 25 May 2023 | | ||
Itron, Inc. Utilities | Other 26 May 2022 | | ||
Oxford Students | Other 26 Aug 2019 | |